Analysis of Risk Factors for Death from Melanoma and Genitourinary Diseases in Male Patients with Cutaneous Melanoma: A Cohort Propensity Score Matching Study DOI Creative Commons
Richard C. Wang, Weiwei Wu, Yongbao Wei

et al.

Clinical Cosmetic and Investigational Dermatology, Journal Year: 2024, Volume and Issue: Volume 17, P. 2323 - 2333

Published: Oct. 1, 2024

To analyze the influencing factors of male cutaneous melanoma (CM) patients dying from genitourinary diseases (GUD).

Language: Английский

An Evaluation of Sentinel Lymph Node Biopsy Guideline Adherence in Melanoma DOI

Adriana Doren,

Hemali Shah, Ashar Ata

et al.

Annals of Surgical Oncology, Journal Year: 2025, Volume and Issue: unknown

Published: Feb. 7, 2025

Language: Английский

Citations

2
Sentinel Node Biopsy in Melanoma Remains a Valuable Clinical Tool. Comment on Dixon et al. Primary Cutaneous Melanoma—Management in 2024. J. Clin. Med. 2024, 13, 1607 DOI Open Access
Thomas E. Pennington, John F. Thompson

Journal of Clinical Medicine, Journal Year: 2025, Volume and Issue: 14(1), P. 215 - 215

Published: Jan. 2, 2025

Management of melanoma in 2024 requires at times complex decision making and a multidisciplinary approach. An article by Dixon collaborators published this Journal contained broad-reaching recommendations, some which are contradiction accepted National International Guidelines. This seeks to highlight these points contention outline widely standards care that considered best practice.

Language: Английский

Citations

1
Gold nanostructures in melanoma: Advances in treatment, diagnosis, and theranostic applications DOI Creative Commons

Zahra Sadat Dastgheib,

Samira Sadat Abolmaali, Ghazal Farahavar

et al.

Heliyon, Journal Year: 2024, Volume and Issue: 10(15), P. e35655 - e35655

Published: Aug. 1, 2024

Melanoma, a lethal form of skin cancer, poses significant challenge in oncology due to its aggressive nature and high mortality rates. Gold nanostructures, including gold nanoparticles (GNPs), offer myriad opportunities melanoma therapy imaging their facile synthesis functionalization, robust stability, tunable physicochemical optical properties, biocompatibility. This review explores the emerging role nanostructures composites revolutionizing treatment paradigms, bridging gap between nanotechnology clinical oncology, offering insights for researchers, clinicians, stakeholders. It begins by elucidating potential nanotechnology-driven approaches cancer therapy, highlighting unique properties versatility GNPs biomedical applications. Various therapeutic modalities, photothermal photodynamic targeted drug delivery, gene nanovaccines, are discussed detail, along with from ongoing trials. In addition, utility theranostics is explored, showcasing diagnosis, monitoring, personalized medicine. Furthermore, safety considerations toxicities associated addressed, underscoring importance comprehensive risk assessment translation. Finally, concludes discussing current challenges future directions, emphasizing need innovative strategies maximize impact therapy.

Language: Английский

Citations

5
Effects of Age, Gender, Histopathology, and Anatomical Location of the Lesion on BRAF Mutation in Turkish Cutaneous Melanoma Patients DOI

Faruk Taş

Indian Journal of Surgery, Journal Year: 2025, Volume and Issue: unknown

Published: March 5, 2025

Language: Английский

Citations

0
Melanoma thickness and long-term mortality DOI Open Access
Paolo Vineis

JNCI Journal of the National Cancer Institute, Journal Year: 2024, Volume and Issue: unknown

Published: Sept. 20, 2024

Language: Английский

Citations

0
Analysis of Risk Factors for Death from Melanoma and Genitourinary Diseases in Male Patients with Cutaneous Melanoma: A Cohort Propensity Score Matching Study DOI Creative Commons
Richard C. Wang, Weiwei Wu, Yongbao Wei

et al.

Clinical Cosmetic and Investigational Dermatology, Journal Year: 2024, Volume and Issue: Volume 17, P. 2323 - 2333

Published: Oct. 1, 2024

To analyze the influencing factors of male cutaneous melanoma (CM) patients dying from genitourinary diseases (GUD).

Language: Английский

Citations

0